Studies of T-cell libraries from patients with MS showed that CCR6+ myelin-reactive T cells exhibit enhanced production of IFN-γ, IL-17, and GM-CSF and reduced production of IL-10, when compared with those from healthy individuals19. This evidence concerns the gene IL17A and myeloid sarcoma.